Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA. Petrella T, et al. Among authors: joly p. Am J Clin Pathol. 2005 May;123(5):662-75. Am J Clin Pathol. 2005. PMID: 15981806 Review.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
Grange F, Petrella T, Beylot-Barry M, Joly P, D'Incan M, Delaunay M, Machet L, Avril MF, Dalac S, Bernard P, Carlotti A, Esteve E, Vergier B, Dechelotte P, Cassagnau E, Courville P, Saiag P, Laroche L, Bagot M, Wechsler J. Grange F, et al. Among authors: joly p. Blood. 2004 May 15;103(10):3662-8. doi: 10.1182/blood-2003-08-2726. Epub 2004 Jan 15. Blood. 2004. PMID: 14726400 Free article.
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J, Estève E, Bagot M, Bernard P, Beylot-Barry M, Delaunay M, D'Incan M, Souteyrand P, Vaillant L, Cordel N, Courville P, Joly P. de Quatrebarbes J, et al. Among authors: joly p. Arch Dermatol. 2005 Sep;141(9):1117-20. doi: 10.1001/archderm.141.9.1117. Arch Dermatol. 2005. PMID: 16172308 Clinical Trial.
Rituximab for pemphigus vulgaris.
Joly P, D'Incan M, Musette P. Joly P, et al. N Engl J Med. 2007 Feb 1;356(5):521; author reply 521-2. doi: 10.1056/NEJMc063290. N Engl J Med. 2007. PMID: 17267915 No abstract available.
Neurological disorders in patients with bullous pemphigoid.
Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, Bernard P, D'Incan M, Roujeau JC, Joly P; French Study Group of Bullous Diseases. Cordel N, et al. Among authors: joly p. Dermatology. 2007;215(3):187-91. doi: 10.1159/000106574. Dermatology. 2007. PMID: 17823513
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T. Grange F, et al. Among authors: joly p. Arch Dermatol. 2007 Sep;143(9):1144-50. doi: 10.1001/archderm.143.9.1144. Arch Dermatol. 2007. PMID: 17875875
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
Quereux G, Marques S, Nguyen JM, Bedane C, D'incan M, Dereure O, Puzenat E, Claudy A, Martin L, Joly P, Delaunay M, Beylot-Barry M, Vabres P, Celerier P, Sasolas B, Grange F, Khammari A, Dreno B. Quereux G, et al. Among authors: joly p. Arch Dermatol. 2008 Jun;144(6):727-33. doi: 10.1001/archderm.144.6.727. Arch Dermatol. 2008. PMID: 18559761
943 results